Teva Pharmaceutical Industries Limited stock news

Teva Pharmaceutical Industries Limited stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

1 wire items

2026-08-19 12:30:55 UTC#195044newconfirmednews

FDA grants priority review to Teva's Ecopipam for pediatric Tourette syndrome

reutersimportance 0.60trust 0.90Teva Pharmaceutical Industries Limited +0.50U.S. Food and Drug Administration +0.40Ecopipam +0.50